Navigation Links
Depression doubles mortality risk after CABG

Patients with depression are more than twice as likely to die after coronary artery bypass grafting (CABG) than patients without this mental illness, according to researchers.//

Other studies examining the link between depression and CABG outcomes have been unable to reach solid conclusions either because of small sample size or short follow-up.

Dr. Blumenthal and colleagues, from Duke University Medical Centers in Durham, North Carolina, assessed the outcomes of 817 patients who underwent CABG between May 1989 and May 2001. The patients completed a validated test of depression before and 6 months after surgery. The average follow-up period was 5.2 years and 122 patients died.

Based on test scores, 38% of patients met the criterion for depression, after controlling for a variety of confounders, such as age, sex, diabetes, smoking, and number of grafts, moderate-to-severe depression at baseline independently increased the risk of death by 2.4-fold (p = 0.001). Similarly, depression that persisted from baseline to 6 months was linked to a 2.2-fold increased mortality risk (p = 0.015).

The results suggest that "physicians need to be more cognizant of the potential importance of depression," Dr. Blumenthal noted. "In addition to looking at conventional cardiac risk factors, such as hypertension and smoking, physicians need to pay attention to a person's mental state."

At the very least, having a CABG team member "who screens patients for depression would be worthwhile," he added. "If depression is detected, then a plan for ongoing monitoring and treatment if necessary could be generated."

"Effective treatments for depression are available, but whether these treatments would actually improve survival after CABG is unknown," Dr. Blumenthal pointed out. "But certainly improving quality of life would be a goal in and of itself."
'"/>




Page: 1

Related medicine news :

1. Low Cholesterol Linked to Severe Depression and Violent Behavior in Men
2. Depression may cause delayed wound healing
3. Diabetes and Depression often go hand-in-hand
4. Depression and heart failure
5. Depression disturbs heart rate
6. Depression a possible danger in elderly
7. Depression linked to mortality
8. Depression increases heart attacks
9. More People Seeking Treatment for Depression
10. Depression elevates heart failure risk
11. Depression hurts the heart
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/19/2017)... Fla. (PRWEB) , ... August 19, 2017 , ... ... Taufiq Ahmed, M.D., has joined its Orlando location as an interventional pain management ... anesthesiology, a focus on the treatment of migraine headaches, and significant experience in ...
(Date:8/18/2017)... ... August 18, 2017 ... ... For Immediate Release                Contact: Julian Teixeira, August 18, 2017                    202-478-8564 / ... Relationship Advice from their Fathers , Contrary to a ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... “Vision & Hearing” campaign, advocating for active, healthy lifestyles and highlighting the importance ... for individuals with hearing impairments and shares the latest innovations in hearing aid ...
(Date:8/18/2017)... ... August 18, 2017 , ... Radabaugh & Associates, ... to communities in North-Central West Virginia, is embarking on a cooperative charity effort ... the area. , The Chestnut Mountain Ranch (CMR) is a Christ-centered boarding school ...
(Date:8/18/2017)... ... August 18, 2017 , ... Goss & ... serves residential and commercial clients in the greater Houston region, is helping locally ... for the fight against cancer. , Founded by Tony and Amber Bender after ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Inc., the creator of the drug Truveta for the treatment ... IPO. The United States spends approximately ... prescription epilepsy drug being $450.00-$1200.00 for a one month supply. ... AXIUM PHARMACEUTICALS, INC ... is the fact that Americans spent $42 billion on anxiety medications last ...
(Date:8/14/2017)... HACKENSACK, N.J. and PETACH TIKVAH, ... Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult ... for the second quarter ending June 30, 2017. ... advanced stages of preparing for our pivotal Phase 3 ... Chaim Lebovits , President and Chief Executive Officer ...
(Date:8/8/2017)...  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company ... results for the second quarter ended June 30, 2017. ... 2017 and to date: ... the Company,s lead project, BL-8040: Announced ... as novel stem cell mobilization treatment for autologous bone-marrow ...
Breaking Medicine Technology: